Intrinsic Value of S&P & Nasdaq Contact Us

Amedisys, Inc. AMED NASDAQ

NASDAQ Global Select • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score
60/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$143.38
+42%

Amedisys, Inc. (AMED) is a publicly traded company in the Healthcare sector, operating within the Medical - Care Facilities industry. The company is headquartered in Baton Rouge, LA, United States. The current CEO is Richard M. Ashworth.

AMED has IPO date of 1994-08-17, 19,000 full-time employees, listed on the NASDAQ Global Select, a market capitalization of $3.32B.

About Amedisys, Inc.

Amedisys, Inc. is a leading U.S. healthcare services provider operating through four business segments: Home Health, Hospice, Personal Care, and High Acuity Care. The company delivers skilled nursing, rehabilitation therapy, and supportive services to patients in their homes, helping them recover from surgery, manage chronic conditions, and avoid preventable hospital readmissions. Its Hospice segment provides comfort care for patients with terminal illnesses, while Personal Care and High Acuity Care segments offer assistance with daily living activities and in-home hospital-level care, respectively. As of December 31, 2021, Amedisys operated 331 home health centers, 175 hospice centers, 14 personal care centers, and 8 high acuity care centers across 38 states and the District of Columbia. Founded in 1982 and headquartered in Baton Rouge, Louisiana, the company serves as a comprehensive home-based healthcare provider in the United States.

📍 3854 American Way, Baton Rouge, LA 70816 📞 225 292 2031
Company Details
SectorHealthcare
IndustryMedical - Care Facilities
CountryUnited States
ExchangeNASDAQ Global Select
CurrencyUSD
IPO Date1994-08-17
CEORichard M. Ashworth
Employees19,000
Trading Info
Current Price$100.99
Market Cap$3.32B
52-Week Range82.15-101.02
Beta0.90
ETFNo
ADRNo
CUSIP023436108
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message